Add to ORKGAbstract Objective To develop an evidence base for recommendations on the use of atypical antipsychotics for patients with schizophrenia
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiven...
OBJECTIVE: To develop an evidence base for recommendations on the use of atypical antipsychotics for...
Supplementary Materials: Reappraising the variability of effects of antipsychotic medication in schi...
Supplementary Materials: Reappraising the variability of effects of antipsychotic medication in schi...
Objective To develop an evidence base for recommendations on the use of atypical antipsychotics for ...
Antipsychotic drugs constitute the mainstay in the treatment of schizophrenia, and their efficacy is...
Background: The question of which antipsychotic drug should be preferred for the treatment of schizo...
Abstract Randomized controlled trials (RCTs) have been considered as gold standard for establishing ...
BACKGROUND: The question of which antipsychotic drug should be preferred for the treatment of schiz...
© 2019 American Chemical Society. All rights reserved. Importance: An assumption among clinicians an...
Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...
Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...
© 2019 American Chemical Society. All rights reserved. Importance: An assumption among clinicians an...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiven...
OBJECTIVE: To develop an evidence base for recommendations on the use of atypical antipsychotics for...
Supplementary Materials: Reappraising the variability of effects of antipsychotic medication in schi...
Supplementary Materials: Reappraising the variability of effects of antipsychotic medication in schi...
Objective To develop an evidence base for recommendations on the use of atypical antipsychotics for ...
Antipsychotic drugs constitute the mainstay in the treatment of schizophrenia, and their efficacy is...
Background: The question of which antipsychotic drug should be preferred for the treatment of schizo...
Abstract Randomized controlled trials (RCTs) have been considered as gold standard for establishing ...
BACKGROUND: The question of which antipsychotic drug should be preferred for the treatment of schiz...
© 2019 American Chemical Society. All rights reserved. Importance: An assumption among clinicians an...
Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...
Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...
© 2019 American Chemical Society. All rights reserved. Importance: An assumption among clinicians an...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: The literature on antipsychotic medication in psychosis lack systematization of the empi...
Background: For treatment of patients diagnosed with schizophrenia, comparative long-term effectiven...